India, Sept. 8 -- onix Pharmaceuticals Holding Corp. (TNXP) announced the promotion of Thomas Englese, MBA, to Chief Commercial Officer, effective immediately.
Englese has served as Tonix's Executive Vice President, Commercial Operations, since September 2024 and has led the company's commercial organization, including the U.S. launch of TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults.
TONMYA is a non-opioid treatment for fibromyalgia and represents Tonix's flagship internally developed commercial product.
Since its launch, the company has focused on expanding access, increasing awareness among healthcare providers and patients, and growing prescriptions and sales.
As Chief Commercial Officer,...